|
2026 Journal Article Alpha-particle therapy with an actinium-225 labeled bivalent inhibitor of prostate-specific membrane antigen is therapeutically efficacious in a mouse model of prostate cancerMorgan, Katherine A., Grieve, Melyssa L., Akhter, Dewan T., Lange, Jaclyn L., Harris, Matthew J., Thurecht, Kristofer J., Paterson, Brett M. and Donnelly, Paul S. (2026). Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer. Journal of Medicinal Chemistry acs.jmedchem.6c01378. doi: 10.1021/acs.jmedchem.6c01378 |
|
2025 Conference Publication Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type IIAlmass, Adrian, Paterson, Brett, Humphries, James, Grieve, Melyssa, Stimson, Damion, Migotto, Mary-anne, Cowin, Gary and Reutens, David (2025). Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109196 |
|
2025 Conference Publication Developing a new chelator for the rapid and stable complexation of the α-generators 212Bi and 212PbGrieve, Melyssa, Davey, Patrick, Bernhardt, Paul, Forsyth, Craig and Paterson, Brett (2025). Developing a new chelator for the rapid and stable complexation of the α-generators 212Bi and 212Pb. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11 - 15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109246 |
|
2024 Journal Article Rapid and stable complexation of the α-generators bismuth-212 and lead-212 with a tetraazamacrocyclic chelator bearing thiosemicarbazone pendant armsGrieve, Melyssa L., Davey, Patrick R. W. J., Bernhardt, Paul V., Forsyth, Craig M. and Paterson, Brett M. (2024). Rapid and stable complexation of the α-generators bismuth-212 and lead-212 with a tetraazamacrocyclic chelator bearing thiosemicarbazone pendant arms. Inorganic Chemistry Frontiers, 11 (21), 7307-7323. doi: 10.1039/d4qi01338g |
|
2022 Journal Article The evolving coordination chemistry of radiometals for targeted alpha therapyGrieve, Melyssa L. and Paterson, Brett M. (2022). The evolving coordination chemistry of radiometals for targeted alpha therapy. Australian Journal of Chemistry, 75 (2), 65-88. doi: 10.1071/CH21184 |
|
2021 Journal Article The synthesis of a bis(Thiosemicarbazone) macrocyclic ligand and the Mn(II), Co(II), Zn(II) and 68Ga(III) complexesGrieve, Melyssa L., Davey, Patrick R. W. J., Forsyth, Craig M. and Paterson, Brett M. (2021). The synthesis of a bis(Thiosemicarbazone) macrocyclic ligand and the Mn(II), Co(II), Zn(II) and 68Ga(III) complexes. Molecules, 26 (12) 3646, 3646. doi: 10.3390/molecules26123646 |
